Skip NavigationSkip to Content
Return Return to Search Results

TNF-related apoptosis-inducing ligand as a therapeutic agent in autoimmunity and cancer

  1. Author:
    Cretney, E.
    Shanker, A.
    Yagita, H.
    Smyth, M. J.
    Sayers, T. J.

  2. Author Address

    NCI, Basic Res Program, SAIC Frederick Inc, Expt Immunol Lab,Ctr Canc Res, Frederick, MD 21702 USA. Peter MacCallum Canc Ctr, Sir Donald & Lady Trescowthick Labs, Canc Immunol Program, Melbourne, Vic, Australia. Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 113, Japan Sayers, TJ, NCI, Basic Res Program, SAIC Frederick Inc, Expt Immunol Lab,Ctr Canc Res, Frederick, MD 21702 USA
    1. Year: 2006
    2. Date: FEB
  2. Journal: Immunology and Cell Biology
    1. 84
    2. 1
    3. Pages: 87-98
  4. Type of Article: Review
  1. Abstract:

    Recombinant, soluble TNF-related apoptosis-inducing ligand (TRAIL) is currently being developed as a promising natural immune molecule for trial in cancer patients because it selectively induces apoptosis in transformed or stressed cells but not in most normal cells. In cancer patients, phase 1 and 2 clinical trials using agonistic mAbs that engage the human TRAIL receptors DR4 and DR5 have also provided encouraging results. It is now evident that TRAIL suppresses autoimmune disease in various experimental animal models, suggesting that the therapeutic value of recombinant TRAIL and agonistic DR4 and DR5 mAbs might also extend to the suppression of autoimmune disease. This review provides an insight into our current understanding of the role(s) of TRAIL in disease, with a specific focus on cancer and autoimmunity. We also emphasize biological agents and drugs that sensitize tumour cells to TRAIL-mediated apoptosis and discuss the potential molecular basis for their sensitization

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1111/j.1440-1711.2005.01413.x
  3. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel